Abstract. Requirements about the quality of medical guidelines can be represented using schemata borrowed from the theory of abductive diagnosis, using temporal logic to model the time-oriented aspects expressed in a guideline. In this paper, we investigate how this approach can be mapped to the facilities offered by a theorem proving system for program verification, KIV. It is shown that the reasoning that is required for checking the quality of a guideline can be mapped to such theoremproving facilities. The medical quality of an actual guideline concerning diabetes mellitus 2 is investigated in this way, and some problems discovered are discussed.
Introduction
Health-care is becoming more and more complicated at an astonishing rate. On the one hand, the number of different patient management options has risen considerably during the last couple of decades, whereas, on the other hand, medical doctors are expected to take decisions balancing benefits for the patient against financial costs. There is a growing trend within the medical profession to believe that clinical decision-making should be based as much as possible on sound scientific evidence; this has become known as evidence-based medicine [12] . Evidence-based medicine has given a major impetus to the development of guidelines, documents offering a detailed description of steps that must be taken and considerations that must be taken into account by health-care professionals in managing a disease in a patient to avoid substandard practices or outcomes. Their general aim is to promote standards of medical care.
Researchers in artificial intelligence (AI) have picked up on these developments, and some of them, for example in the Asgaard project [10] , are involved in the design of computer-oriented languages, tools and systems that support the design and deployment of medical guidelines. AI researchers see guidelines as good real-world examples of highly structured, systematic documents that are amenable to formalisation.
There are two approaches to checking the quality of medical guidelines: (1) the object-level approach amounts to translating a guideline to a formal language, such as Asbru [10] , and next applying techniques from program verification to the resulting representation in establishing partial or total correctness; (2) the meta-level approach, which consists of formalising general properties to which a guideline should comply, and then investigating whether this is the case. Here we are concerned with the meta-level approach to guideline-quality checking. For example, a good-quality medical guideline regarding treatment of a disorder should preclude the prescription of redundant drugs, or advise against the prescription of treatment that is less effective than some alternative. Carrying out such checks could be valuable, in particular during the process of designing medical guidelines.
In this paper we explore the route from an informal medical guideline to its logical formalisation and verification. Previously we have shown that the theory of abductive diagnosis can be taken as a foundation for the formalisation of quality criteria of a medical guideline [7] . In this paper we study the use of logical deduction using temporal logic to formally establish whether a guideline fulfils particular quality requirements. For this purpose use was made of the theorem prover KIV [1] . This is a somewhat unusual approach, as KIV and its underlying logics are especially targeted at the verification of parallel programs, whereas here we are concerned with a type of reasoning that comes from AI.
The paper is organised as follows. In the next section, we start by explaining what medical guidelines are, and a method for formalising guidelines by temporal logic, including the logic supported by the theorem prover KIV, are briefly reviewed. In Section 3 the formalisation of guideline quality using a meta-level schema which comes from the theory of abductive diagnosis is described. The guideline on the management of diabetes mellitus type 2 that has been used in the case study is given attention to in Section 4 and a formalisation of this is given. The approach to checking the quality of this guideline using the deductive machinery offered by KIV is presented in Section 5. Finally, Section 6 discusses what has been achieved and suggests some future plans for research.
Preliminaries

The Design of Medical Guidelines
The design of a medical guideline is far from easy. Firstly, the gathering and classification of the scientific evidence underlying and justifying the recommendations mentioned in a guideline is time consuming, and requires considerable expertise in the medical field concerned. Secondly, medical guidelines are very detailed, and making sure that all the information contained in the guideline is complete for the guideline's purpose, and based on sound medical principles is hard work. An example of a tiny portion of a guideline is shown in Fig. 1 ; it is part of the guideline for general practitioners about the treatment of diabetes mellitus type 2. This guideline fragment is used in this paper as a running example.
-Step 1: diet -Step 2: if Quetelet Index (QI) ≤ 24, prescribe a sulfonylurea drug; otherwise, prescribe a biguanide drug -Step 3: combine a sulfonylurea drug and biguanide (replace one of these by a α-glucosidase inhibitor if side-effects occur) -Step 4: one of the following:
• oral antidiabetics and insulin • only insulin One way to use formal methods in the context of guidelines is to automatically verify whether a medical guideline fulfils particular properties, such as whether it complies with quality indicators as proposed by health-care professionals [8] . For example, using particular patient assumptions such as that after treatment the levels of a substance are dangerously high or low, it is possible to check whether this situation does or does not violate the guideline. However, verifying the effects of treatment as well as examining whether a developed medical guideline complies with global criteria, such as that it avoids the prescription of redundant drugs, or the request of tests that are superfluous, is difficult to impossible if only the guideline text is available. Thus, the capability to check whether a guideline fulfils particular medical objectives may require the availability of more medical knowledge than is actually specified in a medical guideline, i.e. background knowledge is required. Table 1 . Used temporal operators; t stands for a time instance.
Notation Interpretation
Formal semantics Hϕ ϕ has always been true in the past t Hϕ ⇔ ∀t < t : t ϕ Gϕ ϕ is true at all future times t Gϕ ⇔ ∀t ≥ t : t ϕ
Using Temporal Logic for Guideline Representation
As medical management is a time-oriented process, diagnostic and treatment actions described in guidelines are performed in a temporal setting. It has been shown previously that the step-wise, possibly iterative, execution of a guideline, such as the example in Fig. 1 , can be described precisely by means of temporal logic [8] . This is a modal logic, where relationships between worlds in the usual possible-world semantics of modal logic is understood as time order, i.e. formulae are interpreted in a temporal structure F = (T, <, I). We will assume that the progression in time is linear, i.e. < is a strict linear order. For the representation of the medical knowledge involved it appeared to be sufficient to use rather abstract temporal operators as proposed in literature [7] . The language of standard logic, with equality and unique names assumption, is augmented with the modal operators G, H, P and F, where the temporal semantics of the first two operators is defined in Table 1 . The last two operators are simply defined in terms of the first two operators:
Pϕ ↔ ¬H¬ϕ (somewhere in the past) Fϕ ↔ ¬G¬ϕ (somewhere in the future)
This logic offers the right abstraction level to cope with the nature of the temporal knowledge in medical guidelines required for our purposes. However, more fine-grained temporal operators can be added if needed. For a full axiomatisation of this logic, see Ref. [11] . Even though this logic was shown to be suitable for representation purposes, we had to map it to the temporal logic underlying KIV, which we had chosen as the system to be used for formal verification. As a consequence, in the next section, this temporal logic is briefly described. The mapping is given in Section 5.1.
Temporal Logic in KIV
The interactive theorem prover KIV offers support for future-time linear temporal logic [2] . Reactive systems can be described in KIV by means of state-charts or parallel programs; here we use parallel programs. A state of a system can be described by first-order logic. Furthermore, static variables v, which have the same values at each time point, are distinguished from dynamic variables V . A specialty of KIV is the use of primed and double-primed variables: a primed variable V represents the value of this variable after a system transition, the double-primed variable V is interpreted as the value after an environment transition. System and environment transitions alternate, with V being equal to V in the successive state.
The supported future-time temporal operators include the operators from Table 2 , where succ(t) is the set of zero or one successors of t. Note that all formulae are interpreted with respect to the first point of time. Let e denote an arbitrary (first-order) expression, then constructs for parallel programs include: V := e (assignments), if ψ then φ 1 else φ 2 (conditionals), while ψ do φ (loops), var V = e in φ (local variables), patom φ end (atomic execution), φ 1 φ 2 (interleaved execution), and p(e, V ) (call to procedure p with value parameters e and var parameters V ).
A temporal logic property for a parallel program is verified in KIV by symbolic execution with induction. Hence, there is a major difference between the temporal logic underlying KIV and the one discussed in the previous section, both in intention and in expressive power. 
-Knowledge concerning the (patho)physiological mechanisms underlying the disease, and the way treatment influences these mechanisms. The knowledge involved could be causal in nature, and is an example of object-knowledge. -Knowledge concerning good practice in treatment selection; this is metaknowledge.
Below we present some ideas on how such knowledge may be formalised using temporal logic (cf. [5] for earlier work). We are interested in the prescription of drugs, taking into account their mode of action. Abstracting from the dynamics of their pharmacokinetics, this can be formalised in logic as follows:
where d is the name of a drug or possibly of a group of drugs indicated by a predicate symbol (e.g. SU(x), where x is universally quantified and 'SU' stands for sulfonylurea drugs, such as Tolbutamid), r is a (possibly negative or empty) requirement for the drug to take effect, and m k is a mode of action, such as decrease of release of glucose from the liver, which holds at all future times.
The modes of action m k can be combined, together with an intention n (achieving normoglycaemia, i.e. normal blood glucose levels, for example), a particular patient condition c, and requirements r j for the modes of action to be effective:
Good practice medicine can then be formalised as follows. Let B be background knowledge, T ⊆ {d 1 , . . . , d p } be a set of drugs, C a collection of patient conditions, R a collection of requirements, and N a collection of intentions which the physician has to achieve. A set of drugs T is a treatment according to the theory of abductive reasoning if [9, 6] : O ⊂ (T ) ≡ ∀T ⊂ T : T is not a treatment according to (1) and (2) i.e. the minimum number of effective drugs are being prescribed. 
where c(T ) = d∈T cost(d); combining the two definitions also makes sense. For example, one could come up with a definition of O ⊂,c that among two subsetminimal treatments selects the one that is the cheapest in financial or ethical sense.
Management of Diabetes Mellitus Type 2
Diabetes Type 2 Background Knowledge
It is well known that diabetes type 2 is a very complicated disease. Here we focus on the derangement of glucose metabolism in diabetic patients; however, even that is nontrivial. To support non-expert medical doctors in the management of this complicated disease in patients, access to a guideline is really essential. One would expect that as this disorder is so complicated, the diabetes mellitus type 2 guideline is also complicated. This, however, is not the case, as may already be apparent from the guideline fragment shown in Fig. 1 . This indicates that much of the knowledge concerning diabetes mellitus type 2 is missing from the guideline, and that without this background knowledge it will be impossible to spot the sort of flaws we are after. Hence, the conclusion is that a deeper biological analysis is required, the results of which are presented below.
The protein hormone insulin, which is produced by the B cells in the Langerhans islets of the pancreas, has the following major effects:
-it increases the uptake of glucose by the liver, where it is stored as glycogen, and inhibits the release of glucose from the liver;
-it increases the uptake of glucose by insulin-dependent tissues, such as muscle and adipose tissue.
At some stage in the natural history of diabetes mellitus type 2, the level of glucose in the blood is too high (hyperglycaemia) due to the decreased production of insulin by the B cells. Treatment of diabetes type 2 consists of:
-Use of sulfonylurea (SU) drugs, such as tolbutamid. These drugs stimulate the B cells in producing more insulin, and if the cells are not completely exhausted, the hyperglycaemia can thus be reverted to normoglycaemia (normal blood glucose levels). -Use of biguanides (BG), such as metformin. These drugs inhibit the release of glucose from the liver. -Use of α-glucosidase inhibitors. These drugs inhibit (or delay) the absorption of glucose from the intestines. We omit considering these drugs in the following, as they are only prescribed when treatment side-effects occur. -Injection of insulin. This is the ultimate, causal treatment.
The background knowledge concerning the (patho)physiology of the glucose metabolism as summarised above is formalised using temporal logic, and kept as simple as possible. The specification is denoted by B DM2 :
where ⊕ stands for the exclusive OR. Note that when the B-cells are exhausted, increased uptake of glucose by the tissues may not only result in normoglycaemia but also in hypoglycaemia (something not mentioned in the guideline).
Quality Check
As insulin can only be administered by injection, in contrast to the other drugs which are normally taken orally, doctors prefer to delay prescribing insulin as long as possible. Thus, the treatment part of the diabetes type 2 guideline mentions that one should start with prescribing oral antidiabetics (SU or BG, cf. Fig.  1 ). Two of these can also be combined if taking only one has insufficient glucoselevel lowering effect. If treatment is still unsatisfactory, the guideline suggests to: (1) either add insulin, or (2) stop with the oral antidiabetics entirely and to start with insulin. The consequences of various treatment options were examined using the method introduced in Section 3. Hypothetical patients for whom it is the intention to reach a normal level of glucose in the blood (normoglycaemia) are considered, and treatment is selected according to the guideline fragments given in Fig. 1: -Consider a patient with hyperglycaemia due to nearly exhausted B-cells:
holds for T = {Drug(SU), Drug(BG)}, which also satisfies the minimality condition O ⊂ (T ).
-Prescription of treatment T = {Drug(SU), Drug(BG), Drug(insulin)} for a patient with exhausted B-cells, as is suggested by the guideline, yields:
In the last case, it appears that it is possible that a patient develops hypoglycaemia due to treatment; if this possibility is excluded, then the minimality condition O ⊂ (T ), and also O ⊂,c (T ), do not hold since insulin by itself is enough to reach normoglycaemia. In either case, good practice medicine is violated, which is to prescribe as few drugs as possible, taking into account costs and side-effects of drugs. Here, three drugs are prescribed whereas only two should have been prescribed (BG and insulin, assuming that insulin alone is too costly), and the possible occurrence of hypoglycaemia should have been prevented.
Quality Checking using Symbolic Execution with Induction
In the previous section we have seen that temporal logic can be used to formally check a medical guideline, but so far only from a theoretical point of view. Here we will study how such proofs can be constructed semi-automatically in terms of symbolic execution with induction using the theorem prover KIV.
Translation to KIV
In this paper we will only discuss the translation of the constructs that were employed in the formalisation in the previous section. Firstly, the universal quantification of the axioms over all points in time is made explicit. Secondly, the modal operators have to be translated. The only modal operators that were used were G and H. The operator G is semantically equivalent to KIV's 2 operator. However, KIV does not support past-time operators, but as Gabbay et al. have shown [4] , it is possible to translate any temporal formula with past-time operators to an equivalent temporal formula with only future-time operators that includes 'until'. This implies that after translation it is possible, at least in principle, to verify the temporal formulas introduced in sections 3 and 4. Axioms hold over all points in time of which the the ones with past-time formulas are of the following fixed form (see section 3):
We can rewrite this semantically and obtain a pure future-time formula, i.e. a formula with only future-time operators, as follows:
∀t : t (ϕ ∧ H Condition(hyperglycaemia)) → ψ ⇔ ∀t : t (ϕ → ψ) ∨ ¬ H Condition(hyperglycaemia)) ⇔ ∀t : t ϕ → ψ or t H Condition(hyperglycaemia)) ⇔ ∀t : t ϕ → ψ or ¬∀t < t : t Condition(hyperglycaemia) ⇔ ¬∃t : t ¬(ϕ → ψ) and ∀t < t : t Condition(hyperglycaemia) ⇔ ¬ (Condition(hyperglycaemia) until ¬ (φ → ψ))
Specification in KIV
In KIV datatypes are expressed in a many-sorted algebra with possibilities for parameterisation, allowing the creation of specific sorts by defining constraints on the parameters. The sorts with associated data elements required to create a specification of the domain of diabetes mellitus type 2 are listed in Table 3 .
In KIV, functions and predicates are static, i.e. they do not change over time. Therefore, for the formalisation in KIV functions and predicates were mapped to dynamic variables. For example, secretion(B-cells, insulin) was mapped to a dynamic variable named BsecretionI. Since variables in axioms of algebraic specifications are universally quantified, a procedure with name 'patient' was used to bind these variables. This gives each relevant variable a context and prohibits instantiations of axioms with variables that have different names. The axioms (3), (4) and (7) were selected and translated to KIV's syntax as indicated in Section 5.1. In addition, a number of variables were primed to deal with the consistency condition mentioned in Section 3, as will be discussed in Section 5.4. This yielded the following three sequents, denoted by A:
